Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 45.00 | |
100 mg | In stock | $ 58.00 | |
500 mg | In stock | $ 117.00 | |
1 g | In stock | $ 157.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS. |
Targets&IC50 | GABA:43 μM |
Synonyms | PK 26124, RP-54274 |
Molecular Weight | 234.2 |
Formula | C8H5F3N2OS |
CAS No. | 1744-22-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 43 mg/mL (183.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 43 mg/mL (183.6 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Riluzole 1744-22-5 Membrane transporter/Ion channel Neuroscience NMDAR Sodium Channel GABA Receptor Gamma-aminobutyric acid Receptor PK 26124 RP 54274 PK26124 PK-26124 RP54274 γ-Aminobutyric acid Receptor RP-54274 inhibit Na+ channels Inhibitor Na channels inhibitor